190 related articles for article (PubMed ID: 26059097)
21. Identification and characterization of the Oct4 extended transcriptional regulatory region in Guanzhong dairy goat.
Cheng X; Meng S; Deng J; Lai W; Wang H
Genome; 2011 Oct; 54(10):812-8. PubMed ID: 21929360
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
Iida H; Suzuki M; Goitsuka R; Ueno H
Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321
[TBL] [Abstract][Full Text] [Related]
23. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
24. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.
Platzer B; Richter S; Kneidinger D; Waltenberger D; Woisetschläger M; Strobl H
J Immunol; 2009 Jul; 183(1):66-74. PubMed ID: 19535631
[TBL] [Abstract][Full Text] [Related]
25. Cross-talk between aryl hydrocarbon receptor and mitogen-activated protein kinase signaling pathway in liver cancer through c-raf transcriptional regulation.
Borlak J; Jenke HS
Mol Cancer Res; 2008 Aug; 6(8):1326-36. PubMed ID: 18708364
[TBL] [Abstract][Full Text] [Related]
26. Oct4 expression in in-vitro-produced sheep blastocysts and embryonic-stem-like cells.
Sanna D; Sanna A; Mara L; Pilichi S; Mastinu A; Chessa F; Pani L; Dattena M
Cell Biol Int; 2009 Dec; 34(1):53-60. PubMed ID: 19947952
[TBL] [Abstract][Full Text] [Related]
27. Characterization of putative cis-regulatory elements that control the transcriptional activity of the human Oct4 promoter.
Yang HM; Do HJ; Oh JH; Kim JH; Choi SY; Cha KY; Chung HM; Kim JH
J Cell Biochem; 2005 Nov; 96(4):821-30. PubMed ID: 16149048
[TBL] [Abstract][Full Text] [Related]
28. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of oct4 in human bone marrow mesenchymal stem cells.
Wei X; Shen CY
Stem Cells Dev; 2011 Mar; 20(3):441-9. PubMed ID: 20594032
[TBL] [Abstract][Full Text] [Related]
30. Characterization of POU5F1 (OCT4) gene and its promoter in buffalo ESC-like cells identifies multiple transcription start sites and expression of four pseudogenes.
Singh N; George A; Sharma R; Singla SK; Palta P; Manik R; Chauhan MS; Singh D
Gene; 2012 Jan; 491(2):165-72. PubMed ID: 22019428
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
32. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially.
Ciolino HP; Daschner PJ; Yeh GC
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):715-22. PubMed ID: 10359656
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
[TBL] [Abstract][Full Text] [Related]
35. Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis.
Villodre ES; Kipper FC; Pereira MB; Lenz G
Cancer Treat Rev; 2016 Dec; 51():1-9. PubMed ID: 27788386
[TBL] [Abstract][Full Text] [Related]
36. OCT4 Coordinates with WNT Signaling to Pre-pattern Chromatin at the SOX17 Locus during Human ES Cell Differentiation into Definitive Endoderm.
Ying L; Mills JA; French DL; Gadue P
Stem Cell Reports; 2015 Oct; 5(4):490-8. PubMed ID: 26411902
[TBL] [Abstract][Full Text] [Related]
37. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Oct4 overproduction in mouse embryonic stem cells results in prolonged mesoderm commitment during hematopoietic differentiation in vitro.
Camara-Clayette V; Le Pesteur F; Vainchenker W; Sainteny F
Stem Cells; 2006 Aug; 24(8):1937-45. PubMed ID: 16690781
[TBL] [Abstract][Full Text] [Related]
39. OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas.
Shi J; Shi W; Ni L; Xu X; Su X; Xia L; Xu F; Chen J; Zhu J
Oncol Rep; 2013 Jul; 30(1):201-6. PubMed ID: 23670345
[TBL] [Abstract][Full Text] [Related]
40. Curcumin induces apoptotic cell death via Oct4 inhibition and GSK-3β activation in NCCIT cells.
Yun JH; Park YG; Lee KM; Kim J; Nho CW
Mol Nutr Food Res; 2015 Jun; 59(6):1053-62. PubMed ID: 25755051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
